Stay updated with breaking news from Eric Ribner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN JOSE, Calif., March 17, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. , a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that the... | March 17, 2022
/PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases,...
Press release content from NewMediaWire. The AP news staff was not involved in its creation.
Lead DMT-assisted therapy candidate SPL026’s clinical development program strengthened with the addition of two clinical trials planned for 2022 SPL028, a...
Presentation to be webcast on Monday, March 14 at 3:30 – 3:55PM/PT...